المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Hematoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı., Özkocaman, Vildan, Demirkaya, Metin, AAH-1854-2021, 6603145040, 24331130000

مصطلحات موضوعية: Oncology, Hodgkin lymphoma, Resistant/relapsed disease, Programmed death 1 (PD-1) blocker, Nivolumab, Brentuxımab vedotın, PD-1 blockade, Adolescent, Adult, Aged, Antibodies, Monoclonal, Antineoplastic, Agents, Disease-free survival, Female, Hodgkin disease, Humans, Immunoconjugates, Male, Middle aged, Retrospective studies, Stem cell transplantation, Young adult, Brentuximab Vedotin, Hodgkin's Disease, Refractory Materials, Mycophenolate mofetil, Programmed death 1 receptor, Steroid

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; Annals of Oncology; Yurt içi; Sanayi; Beköz, H. vd. (2017). ''Nivolumab for relapsed or refractory Hodgkin lymphoma: Real-life experience''. Annals of Oncology, 28(10), 2496-2502.; https://doi.org/10.1093/annonc/mdx341Test; https://www.sciencedirect.com/science/article/pii/S0923753419349452Test; http://hdl.handle.net/11452/32082Test; 000411827200025; 2-s2.0-85030557671; 2496; 2502; 28; 10

الإتاحة: https://doi.org/10.1093/annonc/mdx341Test
http://hdl.handle.net/11452/32082Test
https://www.sciencedirect.com/science/article/pii/S0923753419349452Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Hematoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı., Özkocaman, Vildan, Demirkaya, Metin, AAH-1854-2021, 6603145040, 24331130000

مصطلحات موضوعية: Oncology, Hodgkin lymphoma, Resistant/relapsed disease, Programmed death 1 (PD-1) blocker, Nivolumab, Brentuxımab vedotın, PD-1 blockade, Adolescent, Adult, Aged, Antibodies, Monoclonal, Antineoplastic, Agents, Disease-free survival, Female, Hodgkin disease, Humans, Immunoconjugates, Male, Middle aged, Retrospective studies, Stem cell transplantation, Young adult, Brentuximab Vedotin, Hodgkin's Disease, Refractory Materials, Mycophenolate mofetil, Programmed death 1 receptor, Steroid

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; Annals of Oncology; Yurt içi; Sanayi; Beköz, H. vd. (2017). ''Nivolumab for relapsed or refractory Hodgkin lymphoma: Real-life experience''. Annals of Oncology, 28(10), 2496-2502.; https://doi.org/10.1093/annonc/mdx341Test; https://www.sciencedirect.com/science/article/pii/S0923753419349452Test; http://hdl.handle.net/11452/32082Test; 000411827200025; 2-s2.0-85030557671; 2496; 2502; 28; 10

الإتاحة: https://doi.org/10.1093/annonc/mdx341Test
http://hdl.handle.net/11452/32082Test
https://www.sciencedirect.com/science/article/pii/S0923753419349452Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı., Mıstık, Reşit, 6602564624

مصطلحات موضوعية: Infectious diseases, Baseline resistance, Hepatitis C virus, Mutation, Protease inhibitors, Genotype 1, Pegylated interferon, Antiviral agents, Virus genotypes, Ribavirin, Telaprevir, Simeprevir, Infection, Polymorphisms, Retreatment, Adult, Aged, 80 and over, Drug resistance, viral, Female, Genotype, Hepacivirus, Hepatitis C, chronic, Humans, Male, Middle aged, Oligopeptides, Proline

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; International Journal of Infectious Diseases; Yurt içi; Yurt dışı; Sanayi; Altunok, E. S. vd. (2016). "Protease inhibitors drug resistance mutations in Turkish patients with chronic hepatitis C". ed. Petersen, E. ve Denmark, A. International Journal of Infectious Diseases, 50, 1-5.; https://doi.org/10.1016/j.ijid.2016.07.003Test; https://www.sciencedirect.com/science/article/pii/S1201971216311109Test; http://hdl.handle.net/11452/29837Test; 000388326300001; 2-s2.0-84979254596; 50

الإتاحة: https://doi.org/10.1016/j.ijid.2016.07.003Test
http://hdl.handle.net/11452/29837Test
https://www.sciencedirect.com/science/article/pii/S1201971216311109Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı., Mıstık, Reşit, 6602564624

مصطلحات موضوعية: Infectious diseases, Baseline resistance, Hepatitis C virus, Mutation, Protease inhibitors, Genotype 1, Pegylated interferon, Antiviral agents, Virus genotypes, Ribavirin, Telaprevir, Simeprevir, Infection, Polymorphisms, Retreatment, Adult, Aged, 80 and over, Drug resistance, viral, Female, Genotype, Hepacivirus, Hepatitis C, chronic, Humans, Male, Middle aged, Oligopeptides, Proline

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; International Journal of Infectious Diseases; Yurt içi; Yurt dışı; Sanayi; Altunok, E. S. vd. (2016). "Protease inhibitors drug resistance mutations in Turkish patients with chronic hepatitis C". ed. Petersen, E. ve Denmark, A. International Journal of Infectious Diseases, 50, 1-5.; https://doi.org/10.1016/j.ijid.2016.07.003Test; https://www.sciencedirect.com/science/article/pii/S1201971216311109Test; http://hdl.handle.net/11452/29837Test; 000388326300001; 2-s2.0-84979254596; 50

الإتاحة: https://doi.org/10.1016/j.ijid.2016.07.003Test
http://hdl.handle.net/11452/29837Test
https://www.sciencedirect.com/science/article/pii/S1201971216311109Test

المساهمون: Uludağ Üniversitesi/Tıp FakültesiGenel Cerrahi Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., orcid:0000-0001-7904-883X, orcid:0000-0002-5956-8755, orcid:0000-0002-3820-424X, orcid:0000-0002-3760-9755, orcid:0000-0002-1619-6680, Öztürk, Ersin, Aksoy, Seçil A. K., Uǧraş, Nesrin, Tunca, Berrin, Ceylan, Serkan, Tezcan, Gülçin, Yılmazlar, Tuncay, Yerci, Ömer, Egeli, Ünal, Çeçener, Gülşah, AAH-1420-2021, AAH-3843-2020, AAP-9988-2020, ADM-8457-2022, AAH-2716-2021, ABI-6078-2020, 35070171400, 36668149100, 55386535600, 6602965754, 57200378423, 25650627600, 6701800362, 6603810549, 55665145000, 6508156530

مصطلحات موضوعية: Immunology, Microbiology, Colon cancer, Early stage, Metastasis-associated colon cancer-1, NME/NM23 nucleoside diphosphate kinase 1, Tumor budding, Epithelial-mesenchymal transition, Colorectal-cancer, Cell-migration, Expression, Gene, Progression, Metastasis, Invasion, Met, Tgf-beta, Adult, Aged, 80 and over, Colonic neoplasms, Female, Gene expression regulation, neoplastic, Humans, Male, Middle aged, Neoplasm recurrence, local, Neoplasm staging

العلاقة: Makale - Uluslararası Hakemli Dergi; T (U)-2012/41; APMIS; Yurt dışı; Öztürk, E. vd. (2018). ''Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer''. APMIS, 126(2), 99-108.; https://doi.org/10.1111/apm.12801Test; http://hdl.handle.net/11452/34741Test; 000423388400001; 2-s2.0-85041038864; 99; 108; 126

الإتاحة: https://doi.org/10.1111/apm.12801Test
http://hdl.handle.net/11452/34741Test

المساهمون: Uludağ Üniversitesi/Tıp FakültesiGenel Cerrahi Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., orcid:0000-0001-7904-883X, orcid:0000-0002-5956-8755, orcid:0000-0002-3820-424X, orcid:0000-0002-3760-9755, orcid:0000-0002-1619-6680, Öztürk, Ersin, Aksoy, Seçil A. K., Uǧraş, Nesrin, Tunca, Berrin, Ceylan, Serkan, Tezcan, Gülçin, Yılmazlar, Tuncay, Yerci, Ömer, Egeli, Ünal, Çeçener, Gülşah, AAH-1420-2021, AAH-3843-2020, AAP-9988-2020, ADM-8457-2022, AAH-2716-2021, ABI-6078-2020, 35070171400, 36668149100, 55386535600, 6602965754, 57200378423, 25650627600, 6701800362, 6603810549, 55665145000, 6508156530

مصطلحات موضوعية: Immunology, Microbiology, Colon cancer, Early stage, Metastasis-associated colon cancer-1, NME/NM23 nucleoside diphosphate kinase 1, Tumor budding, Epithelial-mesenchymal transition, Colorectal-cancer, Cell-migration, Expression, Gene, Progression, Metastasis, Invasion, Met, Tgf-beta, Adult, Aged, 80 and over, Colonic neoplasms, Female, Gene expression regulation, neoplastic, Humans, Male, Middle aged, Neoplasm recurrence, local, Neoplasm staging

العلاقة: Makale - Uluslararası Hakemli Dergi; T (U)-2012/41; APMIS; Yurt dışı; Öztürk, E. vd. (2018). ''Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer''. APMIS, 126(2), 99-108.; https://doi.org/10.1111/apm.12801Test; http://hdl.handle.net/11452/34741Test; 000423388400001; 2-s2.0-85041038864; 99; 108; 126

الإتاحة: https://doi.org/10.1111/apm.12801Test
http://hdl.handle.net/11452/34741Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., orcid:0000-0002-9732-5340, Çubukçu, Erdem, Ölmez, Ömer Fatih, Saraydaroǧlu, Özlem, Akçalı, Ünsal, Kanat, Özkan, Kurt, Ender, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAH-9701-2021, 53986153800, 26435400000, 15074395500, 16027743900, 55881548500, 7006207332, 6603942124, 6602587152

مصطلحات موضوعية: Oncology, Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, Dna-repair, Chemotherapy, Messenger-RNA, Biomarkers, Resistance, Therapy, Gene, Adult, Aged, Antineoplastic agents, Carcinoma, non-small-cell lung, adjuvant, Cisplatin, Disease-free survival, DNA-binding proteins, Endonucleases, Female, Humans, Lung neoplasms, Male, Middle aged, DNA Repair, Value of Repair, Ribonucleotide Reductases

العلاقة: Makale - Uluslararası Hakemli Dergi; Clinical and Translational Oncology; Çubukçu, E. vd. (2011). ''Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: Implications for patient outcome''. Clinical and Translational Oncology, 13(11), 826-830.; https://doi.org/10.1007/s12094-011-0741-7Test; https://link.springer.com/article/10.1007/s12094-011-0741-7Test; http://hdl.handle.net/11452/24546Test; 000297518700012; 2-s2.0-84856052532; 826; 830; 13; 11

الإتاحة: https://doi.org/10.1007/s12094-011-0741-7Test
http://hdl.handle.net/11452/24546Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., orcid:0000-0002-9732-5340, Çubukçu, Erdem, Ölmez, Ömer Fatih, Saraydaroǧlu, Özlem, Akçalı, Ünsal, Kanat, Özkan, Kurt, Ender, Evrensel, Türkkan, Manavoǧlu, Osman, AAJ-1027-2021, AAH-9701-2021, 53986153800, 26435400000, 15074395500, 16027743900, 55881548500, 7006207332, 6603942124, 6602587152

مصطلحات موضوعية: Oncology, Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, Dna-repair, Chemotherapy, Messenger-RNA, Biomarkers, Resistance, Therapy, Gene, Adult, Aged, Antineoplastic agents, Carcinoma, non-small-cell lung, adjuvant, Cisplatin, Disease-free survival, DNA-binding proteins, Endonucleases, Female, Humans, Lung neoplasms, Male, Middle aged, DNA Repair, Value of Repair, Ribonucleotide Reductases

العلاقة: Makale - Uluslararası Hakemli Dergi; Clinical and Translational Oncology; Çubukçu, E. vd. (2011). ''Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: Implications for patient outcome''. Clinical and Translational Oncology, 13(11), 826-830.; https://doi.org/10.1007/s12094-011-0741-7Test; https://link.springer.com/article/10.1007/s12094-011-0741-7Test; http://hdl.handle.net/11452/24546Test; 000297518700012; 2-s2.0-84856052532; 826; 830; 13; 11

الإتاحة: https://doi.org/10.1007/s12094-011-0741-7Test
http://hdl.handle.net/11452/24546Test

المؤلفون: Yılmaz, Yusuf

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Ölmez, Ömer Fatih, Gürel, Selim, 26435400000, 7003706434

مصطلحات موضوعية: Chronic hepatitis B, Chronic hepatitis C, Histopathology, Iron, Prohepcidin, Iron stores, Expression, Infection, Gastroenterology & hepatology, Adult, Aged, Antimicrobial cationic peptides, Case-control studies, Female, Hepatitis B, chronic, Hepatitis C, Humans, Liver cirrhosis, Male, Middle aged, Protein precursors, Young adult, Hepcidins, Metal Transporting Protein 1, Iron-Refractory Iron Deficiency Anemia, Hepcidin, Article, Controlled study, Disease association

العلاقة: Makale - Uluslararası Hakemli Dergi; European Journal of Gastroenterology and Hepatology; Ölmez, Ö. F. vd. (2010). "Plasma prohepcidin levels in patients with chronic viral hepatitis: Relationship with liver fibrosis". European Journal of Gastroenterology and Hepatology, 22(4), 461-465.; https://doi.org/10.1097/MEG.0b013e3283344708Test; https://pubmed.ncbi.nlm.nih.gov/19940783Test/; http://hdl.handle.net/11452/25370Test; 000276566100012; 2-s2.0-77949439229; 461; 465; 22

الإتاحة: https://doi.org/10.1097/MEG.0b013e3283344708Test
http://hdl.handle.net/11452/25370Test
https://pubmed.ncbi.nlm.nih.gov/19940783Test/

المؤلفون: Yılmaz, Yusuf

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Ölmez, Ömer Fatih, Gürel, Selim, 26435400000, 7003706434

مصطلحات موضوعية: Chronic hepatitis B, Chronic hepatitis C, Histopathology, Iron, Prohepcidin, Iron stores, Expression, Infection, Gastroenterology & hepatology, Adult, Aged, Antimicrobial cationic peptides, Case-control studies, Female, Hepatitis B, chronic, Hepatitis C, Humans, Liver cirrhosis, Male, Middle aged, Protein precursors, Young adult, Hepcidins, Metal Transporting Protein 1, Iron-Refractory Iron Deficiency Anemia, Hepcidin, Article, Controlled study, Disease association

العلاقة: Makale - Uluslararası Hakemli Dergi; European Journal of Gastroenterology and Hepatology; Ölmez, Ö. F. vd. (2010). "Plasma prohepcidin levels in patients with chronic viral hepatitis: Relationship with liver fibrosis". European Journal of Gastroenterology and Hepatology, 22(4), 461-465.; https://doi.org/10.1097/MEG.0b013e3283344708Test; https://pubmed.ncbi.nlm.nih.gov/19940783Test/; http://hdl.handle.net/11452/25370Test; 000276566100012; 2-s2.0-77949439229; 461; 465; 22

الإتاحة: https://doi.org/10.1097/MEG.0b013e3283344708Test
http://hdl.handle.net/11452/25370Test
https://pubmed.ncbi.nlm.nih.gov/19940783Test/